Maternal microchimerism and cell‐mediated immune‐modulation enhance engraftment following semi‐allogenic intrauterine transplantation
Autor: | Citra Nurfarah Zaini Mattar, Mahesh Choolani, Vikashini Ravikumar, Yi Wan Tan, Florent Ginhoux, Lay Geok Tan, Jerry Kok Yen Chan, Julie S. L. Yeo, Wanling Foo, Karthikeyan Kandasamy, Nuryanti Johana |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
medicine.medical_treatment Graft vs Host Disease Bone Marrow Cells Stimulation Biochemistry CD19 Andrology Mice 03 medical and health sciences 0302 clinical medicine Immune system Immune Tolerance Genetics Animals Transplantation Homologous Medicine Molecular Biology Bone Marrow Transplantation Mice Inbred BALB C Transplantation Chimera Fetus biology business.industry Graft Survival Hematopoietic Stem Cell Transplantation Transplantation 030104 developmental biology medicine.anatomical_structure Cytokine biology.protein Bone marrow business 030217 neurology & neurosurgery CD8 Biotechnology |
Zdroj: | The FASEB Journal. 35 |
ISSN: | 1530-6860 0892-6638 |
DOI: | 10.1096/fj.202002185rr |
Popis: | Successful intrauterine hematopoietic cell transplantation (IUT) for congenital hemoglobinopathies is hampered by maternal alloresponsiveness. We investigate these interactions in semi-allogenic murine IUT. E14 fetuses (B6 females × BALB/c males) were each treated with 5E+6 maternal (B6) or paternal (BALB/c) bone marrow cells and serially monitored for chimerism (>1% engraftment), trafficked maternal immune cells, and immune responsiveness to donor cells. A total of 41.0% of maternal IUT recipients (mIUT) were chimeras (mean donor chimerism 3.0 ± 1.3%) versus 75.0% of paternal IUT recipients (pIUT, 3.6 ± 1.1%). Chimeras showed higher maternal microchimerism of CD4, CD8, and CD19 than non-chimeras. These maternal cells showed minimal responsiveness to B6 or BALB/c stimulation. To interrogate tolerance, mIUT were injected postnatally with 5E+6 B6 cells/pup; pIUT received BALB/c cells. IUT-treated pups showed no changes in trafficked maternal or fetal immune cell levels compared to controls. Donor-specific IgM and IgG were expressed by 1%-3% of recipients. mIUT splenocytes showed greater proliferation of regulatory T cells (Treg) upon BALB/c stimulation, while B6 stimulation upregulated the pro-inflammatory cytokines more than BALB/c. pIUT splenocytes produced identical Treg and cytokine responses to BALB/c and B6 cells, with higher Treg activity and lower pro-inflammatory cytokine expression upon exposure to BALB/c. In contrast, naive fetal splenocytes demonstrated greater alloresponsiveness to BALB/c compared to B6 cells. Thus pIUT, associated with increased maternal cell trafficking, modulates fetal Treg, and cytokine responsiveness to donor cells more efficiently than mIUT, resulting in improved engraftment. Paternal donor cells may be considered alternatively to maternal donor cells for intrauterine and postnatal transplantation to induce tolerance and maintain engraftment. |
Databáze: | OpenAIRE |
Externí odkaz: |